PMID- 19748581 OWN - NLM STAT- MEDLINE DCOM- 20091224 LR - 20220310 IS - 1873-2518 (Electronic) IS - 0264-410X (Linking) VI - 27 IP - 48 DP - 2009 Nov 12 TI - Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses. PG - 6748-54 LID - 10.1016/j.vaccine.2009.08.106 [doi] AB - Release of outer membrane vesicles is a common feature of Gram negative bacteria. There is growing interest in the use of these vesicles in the development of affordable vaccines. However, to exploit their full potential a convenient system to generate recombinant vesicles would be highly desirable. Here, we report the design of a versatile system for preparation of recombinant outer membrane vesicles based on an engineered autotransporter. Two model vaccine antigens of Leishmania were expressed as fusion proteins with the transporter domain of AIDA, the Escherichia coli adhesin involved in diffuse adhesion. Single subcutaneous injections of recombinant vesicles boosted vaccine antigen-specific antibody responses in mice primed with live recombinant salmonella vaccines by 6-40-fold. The results further show an expansion of only the vaccine antigen-specific antibody response indicating a great potential of this approach for prime boost vaccination strategies. FAU - Schroeder, Juliane AU - Schroeder J AD - Institute of Immunology and Infection Research, University of Edinburgh, UK. FAU - Aebischer, Toni AU - Aebischer T LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090911 PL - Netherlands TA - Vaccine JT - Vaccine JID - 8406899 RN - 0 (AIDA-I protein, E coli) RN - 0 (Adhesins, Escherichia coli) RN - 0 (Antibodies, Bacterial) RN - 0 (Antibodies, Protozoan) RN - 0 (Bacterial Outer Membrane Proteins) RN - 0 (Leishmaniasis Vaccines) RN - 0 (Membrane Glycoproteins) RN - 0 (Protozoan Proteins) RN - 0 (Recombinant Fusion Proteins) RN - 0 (Vaccines, Synthetic) RN - 0 (kinetoplastid membrane protein 11, Leishmania donovani) SB - IM MH - Adhesins, Escherichia coli/immunology MH - Animals MH - Antibodies, Bacterial/blood MH - Antibodies, Protozoan/blood MH - *Antibody Specificity MH - Bacterial Outer Membrane Proteins/immunology MH - Female MH - Immunity, Humoral MH - Leishmania/immunology MH - Leishmaniasis Vaccines/*immunology MH - Membrane Glycoproteins/*immunology MH - Mice MH - Plasmids MH - Protozoan Proteins/*immunology MH - Recombinant Fusion Proteins/immunology MH - Salmonella typhimurium/immunology MH - Transport Vesicles/*immunology MH - Vaccines, Synthetic/immunology EDAT- 2009/09/15 06:00 MHDA- 2009/12/25 06:00 CRDT- 2009/09/15 06:00 PHST- 2009/06/12 00:00 [received] PHST- 2009/08/13 00:00 [revised] PHST- 2009/08/22 00:00 [accepted] PHST- 2009/09/15 06:00 [entrez] PHST- 2009/09/15 06:00 [pubmed] PHST- 2009/12/25 06:00 [medline] AID - S0264-410X(09)01277-8 [pii] AID - 10.1016/j.vaccine.2009.08.106 [doi] PST - ppublish SO - Vaccine. 2009 Nov 12;27(48):6748-54. doi: 10.1016/j.vaccine.2009.08.106. Epub 2009 Sep 11.